First successful protocol for desensitization to eptinezumab

Headache . 2025 Dec 19. doi: 10.1111/head.70000. Online ahead of print. Benoit Gerard , Hubert Praudel , Michel Lanteri-Minet , Elise Van Obberghen , Fanny Rocher-Moreau , Johanna Rousset , Ulysse Jacquier , Sylvie Leroy , Margot Delin  Abstract Background: Eptinezumab is an anti-calcitonin gene-related peptide monoclonal antibody used for

Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France – An analysis of the French National Social Security System Open Data over eleven years (2014-2024)

Revue Neurologique (Paris) . 2025 Dec 16:S0035-3787(25)00653-8. doi: 10.1016/j.neurol.2025.11.004. Online ahead of print. E K Van Obberghen , R Fabre, L Bailly , M Lanteri-Minet  Abstract The burden of cluster headache (CH) requires better knowledge of management to improve it. Objectives: To describe changes in